Stereotactic Radiosurgery With or Without Whole-Brain Radiotherapy for Brain Metastases: Secondary Analysis of the JROSG 99-1 Randomized Clinical Trial

Overview of attention for article published in JAMA Oncology, July 2015

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (94th percentile)
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 32 X users
facebook: 2 Facebook pages

googleplus: 1 Google+ user
guideline: 3 clinical guideline sources

Readers on

mendeley: 150 Mendeley

So far, Altmetric has seen 4 public wall posts from 2 users.

Fratoria BV, 22 Jul 2015

care in focus http://t.co/wMFGWwwcam

JAMA Oncology, 17 Jul 2015

In a secondary analysis of a phase 3 randomized clinical trial, Aoyama and colleagues investigated the feasibility of…

JAMA Oncology, 20 May 2015

Despite the current trend of using stereotactic radiosurgery (SRS) alone, the important role of whole-brain radiotherapy (WBRT…

JAMA Oncology, 15 May 2015

Addition of whole brain radiation therapy to stereotactic radiosurgery is associated with superior survival among patients with…

This page shows the most recent Facebook posts that mention this research output. Click here to find out how to access more activity.